chr17-31318769-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014210.4(EVI2A):c.245A>T(p.His82Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014210.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EVI2A | NM_014210.4 | c.245A>T | p.His82Leu | missense_variant | 2/2 | ENST00000462804.3 | NP_055025.2 | |
NF1 | NM_001042492.3 | c.4836-7051T>A | intron_variant | ENST00000358273.9 | NP_001035957.1 | |||
EVI2A | NM_001003927.3 | c.314A>T | p.His105Leu | missense_variant | 3/3 | NP_001003927.1 | ||
NF1 | NM_000267.3 | c.4773-7051T>A | intron_variant | NP_000258.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EVI2A | ENST00000462804.3 | c.245A>T | p.His82Leu | missense_variant | 2/2 | 1 | NM_014210.4 | ENSP00000420557.3 | ||
ENSG00000265118 | ENST00000578584.5 | c.17A>T | p.His6Leu | missense_variant | 1/3 | 2 | ENSP00000463981.2 | |||
NF1 | ENST00000358273.9 | c.4836-7051T>A | intron_variant | 1 | NM_001042492.3 | ENSP00000351015.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 26, 2024 | The c.314A>T (p.H105L) alteration is located in exon 3 (coding exon 2) of the EVI2A gene. This alteration results from a A to T substitution at nucleotide position 314, causing the histidine (H) at amino acid position 105 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.